Our most interesting finding was that about 30% of our BCM patients on active therapy showed significantly high frequencies of IFN-γ-producing S-specific TCM and TEM CD4+ and CD8+ T lymphocytes (HR patients). This evidence concerns the gene CD4 and blue cone monochromacy.